White Paper

Next Generation Sequencing In The Asia Pacific: The Availability & Reimbursement Landscape

Source: Novotech
Petri dishes with samples for DNA sequencing GettyImages-950425808

Next generation sequencing (NGS) refers to a technology that detects genomic variation that is present at birth or emerges later in life. The introduction of NGS has sparked considerable interest around the world, with demand fueled by the need for better tools to forecast, diagnose, treat, and monitor disease, as well as the advancement of more efficient sequencing technologies.[1] This report describes the availability of NGS in a selection of locations.

NGS provides for the rapid sequencing of a large number of genes at a low cost, which aids in the detection of clinically significant mutations and promotes precision oncology. The NGS test is widely accepted as part of standard cancer care and is being reimbursed in several Western and Asian nations. [2]


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader